Literature DB >> 15668823

An atypical form of erythrokeratodermia variabilis maps to chromosome 7q22.

Thomas G Saba1, Alexandre Montpetit, Andrei Verner, Pierre Rioux, Thomas J Hudson, Régen Drouin, Christian A Drouin.   

Abstract

Erythrokeratodermia variabilis 3 (Kamouraska type) or EKV3 is a newly described autosomal recessive disorder observed in patients from the Bas St-Laurent region of Quebec. It has similar skin lesions as observed for EKV, including congenital hyperkeratosis and red patches of variable sizes, shapes, and duration. EKV3 is also characterized by ichthyosis, sensorineural hearing loss, peripheral neuropathy, psychomotor retardation, congenital chronic diarrhea, and an elevation of very long chain fatty acids (VLCFAs). To map the disease locus, we performed candidate gene analysis and a genomewide scan to identify a common homozygous region in affected individuals from three non-consanguineous families. Mutations in connexin 31 (GJB3) and connexin 30.3 (GJB4), implicated in previous reports of EKV, and connexin 26 (GJB2), implicated in palmoplantar keratoderma, were unlikely given the lack of shared homozygous haplotypes in the regions surrounding these genes. The most promising region of common homozygosity observed in a 4,600 single-nucleotide polymorphism genome scan was further characterized by using microsatellites. A 6.8-Mb region on chromosome 7 between D7S2539 and rs727708 was found to be homozygous for the same haplotype in all affected individuals but not in the parents or an unaffected sibling. This region contains connexin 31.3 (GJE1), and although no mutation have been observed in the coding region of this gene, further analyses are required in order to exclude it. Identification of the gene responsible for this disorder will provide insights into the etiology of this multisystemic disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15668823     DOI: 10.1007/s00439-004-1193-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3.

Authors:  G Richard; N Brown; L E Smith; A Terrinoni; G Melino; R M Mackie; S J Bale; J Uitto
Journal:  Hum Genet       Date:  2000-03       Impact factor: 4.132

2.  Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis.

Authors:  F Macari; M Landau; P Cousin; B Mevorah; S Brenner; R Panizzon; D F Schorderet; D Hohl; M Huber
Journal:  Am J Hum Genet       Date:  2000-10-03       Impact factor: 11.025

3.  Palmoplantar keratoderma of Sybert.

Authors:  Aimee L Leonard; Irwin M Freedberg
Journal:  Dermatol Online J       Date:  2003-10

4.  Reticular erythrokeratoderma: a new disorder of cornification.

Authors:  Peter H Itin; Michael Moschopulos; Gabriela Richard
Journal:  Am J Med Genet A       Date:  2003-07-15       Impact factor: 2.802

Review 5.  Gap junctions and the connexin protein family.

Authors:  Goran Söhl; Klaus Willecke
Journal:  Cardiovasc Res       Date:  2004-05-01       Impact factor: 10.787

Review 6.  Peroxisomal disorders.

Authors:  S Naidu; H W Moser
Journal:  Neurol Clin       Date:  1994-11       Impact factor: 3.806

7.  BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping.

Authors:  Arnold Oliphant; David L Barker; John R Stuelpnagel; Mark S Chee
Journal:  Biotechniques       Date:  2002-06       Impact factor: 1.993

8.  Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis.

Authors:  Laure Plantard; Marcel Huber; Francoise Macari; Paolo Meda; Daniel Hohl
Journal:  Hum Mol Genet       Date:  2003-10-28       Impact factor: 6.150

9.  Connexin 31 (GJB3) is expressed in the peripheral and auditory nerves and causes neuropathy and hearing impairment.

Authors:  N López-Bigas; M Olivé; R Rabionet; O Ben-David; J A Martínez-Matos; O Bravo; I Banchs; V Volpini; P Gasparini; K B Avraham; I Ferrer; M L Arbonés; X Estivill
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

Review 10.  Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins.

Authors:  R Rabionet; P Gasparini; X Estivill
Journal:  Hum Mutat       Date:  2000-09       Impact factor: 4.878

View more
  6 in total

Review 1.  Coatopathies: Genetic Disorders of Protein Coats.

Authors:  Esteban C Dell'Angelica; Juan S Bonifacino
Journal:  Annu Rev Cell Dev Biol       Date:  2019-08-09       Impact factor: 13.827

Review 2.  New directions for the clathrin adaptor AP-1 in cell biology and human disease.

Authors:  Mara C Duncan
Journal:  Curr Opin Cell Biol       Date:  2022-04-13       Impact factor: 8.386

Review 3.  MEDNIK syndrome with a frame shift causing mutation in AP1S1 gene and literature review of the clinical features.

Authors:  Faruk Incecik; Atil Bisgin; Mustafa Yılmaz
Journal:  Metab Brain Dis       Date:  2018-09-23       Impact factor: 3.584

4.  Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord.

Authors:  Alexandre Montpetit; Stéphanie Côté; Edna Brustein; Christian A Drouin; Line Lapointe; Michèle Boudreau; Caroline Meloche; Régen Drouin; Thomas J Hudson; Pierre Drapeau; Patrick Cossette
Journal:  PLoS Genet       Date:  2008-12-05       Impact factor: 5.917

5.  Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein.

Authors:  Andrew Marsh; Katherine Casey-Green; Fay Probert; David Withall; Daniel A Mitchell; Suzanne J Dilly; Sean James; Wade Dimitri; Sweta R Ladwa; Paul C Taylor; Donald R J Singer
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 6.  Disorders of metal metabolism.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.